| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/02/2008 | CN101212987A Self-sterilizing products |
| 07/02/2008 | CN101212986A Stable emulsion composition |
| 07/02/2008 | CN101212984A Process for attaching effector molecules to proteins |
| 07/02/2008 | CN101212965A Topical compositions comprising nanoparticles of an isoflavone |
| 07/02/2008 | CN101212962A Improved formulations of fenofibrate containing menthol or a PEG/poloxamer mixture |
| 07/02/2008 | CN101212960A Eye drop preparation comprising xanthan gum and terpenoid |
| 07/02/2008 | CN101209350A Polyglutamate-medicament coupling compound with amino acid as communicating terminal |
| 07/02/2008 | CN101209349A Application of carbon nano-tube as carrier in transferring anti-cancer medicine |
| 07/02/2008 | CN101209348A Elastic nano vesicle carrier and preparation and application thereof |
| 07/02/2008 | CN101209347A Pharmaceutical compositions of fibrinolytic agent |
| 07/02/2008 | CN101209341A Chinese medicinal preparation, preparation and quality control method thereof |
| 07/02/2008 | CN101209339A Wax candle with incense treating function and preparation method thereof |
| 07/02/2008 | CN101209321A Medicament for treating burn and scald |
| 07/02/2008 | CN101209301A Crab apple soft capsule and preparation technique method |
| 07/02/2008 | CN101209300A Crab apple dispersible tablet and preparation |
| 07/02/2008 | CN101209288A Corydalis decumbentis orally disintegrating tablets |
| 07/02/2008 | CN101209287A Heat-clearing and detoxication antiphlogistic detumescence Chinese medicinal composition and preparation thereof |
| 07/02/2008 | CN101209283A 'Yinhuanghanhua' dropping pill for treating upper respiratory tract infection |
| 07/02/2008 | CN101209272A Panax ginseng super powder effervescent tablets and preparation thereof |
| 07/02/2008 | CN101209270A Application of sugar alcohols in soft extract |
| 07/02/2008 | CN101209269A Application of oligose in soft extract |
| 07/02/2008 | CN101209256A Polydatin medicinal composition containing polyvinyl pyrrolidone |
| 07/02/2008 | CN101209253A Aripiprazole dropping pill and preparation thereof |
| 07/02/2008 | CN101209251A Elastic nano vesicle preparations containing paclitaxel or docetaxel and preparation thereof |
| 07/02/2008 | CN101209250A Compound lignocaine emulsifiable paste and preparing technique |
| 07/02/2008 | CN101209249A Spaston orally disintegrating tablets and preparation thereof |
| 07/02/2008 | CN101209247A Preparation of colon-targeted preparation |
| 07/02/2008 | CN101209246A Novel pH-dependent colon-specific drug delivery system |
| 07/02/2008 | CN101209243A Liposome medicament and preparation thereof |
| 07/02/2008 | CN101209241A Method for preparing medicine targeted controlled-release nano eyedrop |
| 07/02/2008 | CN101209240A Medicine gradient zero level implantation controlled-release drug administration device and preparation thereof |
| 07/02/2008 | CN101209238A Biological degradation type long-acting hypodermal contraception implant containing gestodene and preparation thereof |
| 07/02/2008 | CN101209232A Composition for external use |
| 07/02/2008 | CN101209171A Pillow containing tea, carbon and Chinese herbal medicine composite granules and preparation method thereof |
| 07/02/2008 | CN100398536C Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 07/02/2008 | CN100398094C Formoterol superfine formulation |
| 07/01/2008 | US7395112 Method and apparatus for treating tumors using low strength electric fields |
| 07/01/2008 | US7393953 Polymeric acyl derivatives of indoles |
| 07/01/2008 | US7393928 Recombinant gelatins |
| 07/01/2008 | US7393841 for improved microcirculation, cryo-conservation of blood components such as erythrocytes of granulocytes, and as sedimentation aid in cell separation in connection with leucapheresis |
| 07/01/2008 | US7393840 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 07/01/2008 | US7393828 to be used in pharmaceutical delivery vehicles for controlled and/or localized release of therapeutic molecules (e.g., small molecules, peptides, proteins or other macromolecules). |
| 07/01/2008 | US7393698 Which have acrylic amide polymer immobilized thereto; heat shock proteins |
| 07/01/2008 | US7393657 Diagnosis and treatment of cancer: I |
| 07/01/2008 | US7393548 Mean droplet size below one micron; emulsifying stabilizer such as cetearyl glucoside, sucrose esters or sorbitan esters; cosmetic or pharmaceutical agent |
| 07/01/2008 | US7393545 Lipstatin derivative—soluble fiber tablets |
| 07/01/2008 | US7393544 Microstructures containing a drug and a suspension medium that permeates into the permeable microstructures; density variations between suspended particles and medium are minimized and attractive forces between microstructures are attenuated, resulting in settling and flocculation resistance |
| 07/01/2008 | US7393543 Vaginally administratable progesterone-containing tablets and method for preparing same |
| 07/01/2008 | US7393535 Adjuvants for use in vaccines |
| 07/01/2008 | US7393531 Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 07/01/2008 | US7393478 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 06/26/2008 | WO2008077130A2 Homogeneous paste and gel formulations |
| 06/26/2008 | WO2008077106A1 L-histidine in ophthalmic solutions |
| 06/26/2008 | WO2008076373A1 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| 06/26/2008 | WO2008076333A2 Polymer-drug conjugates with tether groups for controlled drug delivery |
| 06/26/2008 | WO2008075984A2 Tablet formulation including macrocyclic lactone and levamisole anthelmintic agents |
| 06/26/2008 | WO2008075793A1 Composition for promoting bioabsorption of flavonoid, food/beverage for promoting bioabsorption of flavonoid using the composition, and method for production of the food/beverage |
| 06/26/2008 | WO2008075706A1 Therapeutic agent for interstitial pneumonia |
| 06/26/2008 | WO2008075665A1 Transdermally absorbable preparation and adhesive sheet for application to the skin |
| 06/26/2008 | WO2008075448A1 Chitosan solution and medical preparation with chitosan coating formed from the solution |
| 06/26/2008 | WO2008075045A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 06/26/2008 | WO2008075038A1 Binding agents to the integrin alpha-11 subunit |
| 06/26/2008 | WO2008074885A2 Process for manufacturing ophthalmic oil-in-water emulsions |
| 06/26/2008 | WO2008074871A1 Dispersion of polyamino acids in a continuous lipid phase |
| 06/26/2008 | WO2008074865A1 Dimeric prolactin receptor ligands |
| 06/26/2008 | WO2008074853A1 Ophthalmic rebamipide solution |
| 06/26/2008 | WO2008074804A2 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application |
| 06/26/2008 | WO2008074723A1 Inclusion complex of ezetimibe and a cyclodextrin and processes in the preparation thereof |
| 06/26/2008 | WO2008074573A1 Topical dosage form comprising tri-substituted glycerol compounds |
| 06/26/2008 | WO2008074488A2 Construction and use of transfection enhancer elements |
| 06/26/2008 | WO2008074230A1 Interferon alpha mutant and its polyethylene glycol derivative |
| 06/26/2008 | WO2008074216A1 Sterols modified by polyethylene glycol, the preparation and the use thereof |
| 06/26/2008 | WO2008074154A1 Polymers comprising zwitterionic endgroups |
| 06/26/2008 | WO2008074145A1 Pharmaceutical composition comprising a hot-melt granulated lubricant |
| 06/26/2008 | WO2008074108A2 Controlled release pharmaceutical composition of anti-hyperglycemic agent and its preparation |
| 06/26/2008 | WO2008074078A1 Selectively deliverable isatin-based cytotoxic agents |
| 06/26/2008 | WO2008054585A3 Use of pegylated il-10 to treat cancer |
| 06/26/2008 | WO2008041514A9 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 06/26/2008 | WO2008036577A3 Compositions and related methods using soy albumin to provide a variety of health related benefits |
| 06/26/2008 | WO2008030557A9 Compositions and methods for enhancing transport through mucus |
| 06/26/2008 | WO2008003769A3 An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof |
| 06/26/2008 | WO2008001140A3 Pellet formulation comprising colloidal silicon dioxide |
| 06/26/2008 | WO2008000780A3 Inhalant powder containing phenylalanine |
| 06/26/2008 | WO2007137260A3 Preparation of polymer conjugates of vla-4 antagonists via a mitsunobu' s reaction |
| 06/26/2008 | WO2006127514A3 Compositions and methods for treating hiv infection with cupredoxin and cytochrome c |
| 06/26/2008 | US20080154210 Mixture for Transdermal Delivery of Low and High Molecular Weight Compounds |
| 06/26/2008 | US20080154042 Bioavailability, nontoxic; such as 2-(4-dimethylaminophenyl)benzothiazole |
| 06/26/2008 | US20080154030 combining niacin or niacinamide in the aqueous fluid with the cyclodextrin derivative; solubilizers |
| 06/26/2008 | US20080154022 Transport of basic fibroblast growth factor across the blood brain barrier |
| 06/26/2008 | US20080153927 Dicyclomine antispasmodic agent, Mephobarbital barbiturate, Chlordiazepoxide tranquilizer, Citalopram selective serotonin reuptake inhibitor, Alosetron 5-HT3 receptor antagonist; achalasia, Barrett's syndrome, biliary dyskinesia, Crohn's disease, chronic intestinal pseudo-obstruction, colonic inertia |
| 06/26/2008 | US20080153925 Use of Amphiphilic Copolymers as Solubilising Agents |
| 06/26/2008 | US20080153924 Rheological Additive in the Form of a Preactivated Paste |
| 06/26/2008 | US20080153923 Methods of manufacturing copolymers with zwitterionic moieties and dihydroxyphenyl moieties and use of same |
| 06/26/2008 | US20080153915 Pharmaceutical Preparation For the Oral Cavity |
| 06/26/2008 | US20080153900 Administering an anti-microtubule agent such as campothecin, eleutherobin, sarcodictyins, epothilones, discodermolide, deuterium oxide, hexylene glycol, tubercidin or a taxane to treat diseases including psoriasis, arthritis, stenosis, graft rejection, vasculitis and inflammatory lung diseases |
| 06/26/2008 | US20080153865 Water soluble paclitaxel derivatives |
| 06/26/2008 | US20080153793 Coatings comprising self-assembled molecular structures and a method of delivering a drug using the same |
| 06/26/2008 | US20080153740 Methods for increasing protein polyethylene glycol (PEG) conjugation |
| 06/26/2008 | US20080153739 Compositions and methods for treatment of hyperplasia |
| 06/26/2008 | US20080153738 Compositions and methods for treatment of hyperplasia |